| Stage | DUK | % of rev | MDT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.6B | 100.00% | $9.8B | 100.00% | MDT ×1.29 |
| Gross profit | $4.2B | 54.82% | $6.3B | 64.99% | MDT +10.2pp |
| Operating income | $2.0B | 26.99% | $1.8B | 18.08% | DUK +8.9pp |
| Pre-tax income | $1.3B | 17.19% | $1.8B | 18.13% | MDT +0.9pp |
| Net income | $1.1B | 15.08% | $1.5B | 15.16% | MDT +0.1pp |
| Stage | DUK | MDT | Gap · A − B |
|---|---|---|---|
| Revenue | $7.6B100.00% | $9.8B100.00% | MDT ×1.29 |
| Gross profit | 54.82%$4.2B | 64.99%$6.3B | MDT +10.2pp |
| Operating income | 26.99%$2.0B | 18.08%$1.8B | DUK +8.9pp |
| Pre-tax income | 17.19%$1.3B | 18.13%$1.8B | MDT +0.9pp |
| Net income |
| 15.08%$1.1B |
| 15.16%$1.5B |
| MDT +0.1pp |
No shared counterparties.